Goat anti-Glutathione-S-Transferase (GST) Polyclonal antibody

The present study was designed to investigate the correlation between glutathione S-transferase M1 (GSTM1) gene polymorphism and the recovery of patients undergoing artificial hip replacement. A total of 241 patients including 149 males (61.8%) and 92 females (38.9%) who received artificial hip replacement in People's Hospital of Rizhao between December 2010 and October 2016 were enrolled to serve as the observation group. Patients were divided into two subgroups according to the loss of GSTM1. A total of 80 healthy subjects who udenrwent a physical examination in our hospital at the same period were selected to serve as the control group. The control group included 41 males (51.25%) and 39 females (48.75%). GSTM1 gene genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). All patients were followed up for 12 months. Clinical data were compared between the deletion and non-deletion groups and the hospitalization time and the length of the use of antibiotics were compared. Deletion rate of GSTM1 gene in the observation group was 67.63%, which was significantly different from that in the healthy control group [odds ratio (OR)=1.51, 95% confidence interval (CI): 1.075-2.023, P<0.05]. Notably, a significant difference was indicated in the recovery between patients with and without GSTM1 gene deletion after a year discharged from hospital (P<0.05). There was no significant difference according to sex, age, hypertension, smoking history, leukocyte, hemoglobin, platelet and BMI index between patients in deletion and non-deletion groups (P>0.05). However, there was a significant difference in the number of patients with diabetes between the two groups (P<0.05). Hospitalization time and the length of antibiotics use were significantly longer in deletion group compared with non-deletion group (P<0.05). Infection rate in the deletion group was significantly higher than that in the non-deletion group. Results suggested that GSTM1 gene polymorphism may be correlated with recovery of patients undergoing artificial hip replacement, and GSTM1 gene deletion may correlated with poor recovery.

Machine learning employs a variety of statistical, probabilistic, fuzzy and optimization techniques that allow computers to "learn" from examples and to detect hard-to-discern patterns from large, noisy or complex datasets. This capability is well-suited to medical applications, and machine learning techniques have been frequently used in cancer diagnosis and prognosis. In general, machine learning techniques usually work in two phases: training and testing. Some parameters, with regards to the underlying machine learning technique, must be tuned in the training phase in order to best "learn" from the dataset. On the other hand, belief merging operators integrate inconsistent information, which may come from different sources, into a unique consistent belief set (base). Implementations of merging operators do not require tuning any parameters apart from the number of sources and the number of topics to be merged. This research introduces a new manner to "learn" from past examples using a non parametrised technique: belief merging. The proposed method has been used for oral cancer diagnosis using a real-world medical dataset. The results allow us to affirm the possibility of training (merging) a dataset without having to tune the parameters. The best results give an accuracy of greater than 75%. (C) 2017 Published by Elsevier B.V.